undefined undefined
NaN.000
NaN.00%
U.S. stocks traded higher toward the end of trading, with the Dow Jones index g...
05-02 02:32
TransMedics shines with Q1 EPS at $0.35, and sales soared to $96.9 million. Fiscal 2024 revenue outlook raised to $390 million-$400 million. Analysts hail TransMedics' organic growth and strong market position, praising its innovative solutions and promising prospects.
05-02 01:13
Gainers: CytomX Therapeutics (CTMX) +163%. SYLA Technologies Co., Ltd. (SYT) +.42%. New York Community Bancorp (NYCB) +32%. Surmodics (SRDX) +32%. TransMedics Group (TMDX) +27%. DecisionPoint Systems ...
05-02 01:00
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining aro...
05-02 00:17
Gainers: Palisade Bio (PALI) +56% Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysacc...
05-01 20:54
Shares of Pinterest, Inc (NYSE:PINS) rose sharply in today's pre-market trading...
05-01 20:19
TransMedics shares are trading higher after the company raised its 2024 guidanc...
05-01 05:57
TransMedics Group, Inc.'s (NASDAQ:TMDX) price-to-sales (or "P/S") ratio of 10x ...
04-01 22:48
TransMedics Gr's (NYSE:TMDX) short percent of float has risen 8.51% since its l...
03-30 00:45
Piper Sandler launched its coverage of organ care company TransMedics Group (NASDAQ:TMDX) with an Overweight rating and a $95 price target on Thursday, noting its attractive valuation compared to peer...
03-29 00:32